COSTA MESA, Calif.--(BUSINESS WIRE)--Synthetic Blood International, Inc. (OTCBB:SYBD) today announced that it will ask shareholders to approve a name change among other issues in the proxy statement that is being mailed early next week pertaining to a shareholder meeting scheduled for June 17, 2008. The new name proposed for the company is Oxygen Biotherapeutics, Inc.
